At a glance
ClinicalIndex Comparison RecordN/ACompleted· 9,040 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Short- and Long-term Efficacy and Safety Between Ticagrelor and Clopidogrel in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
In Brief
An observational study for Acute Coronary Syndrome. Completed, enrolled 9,040 participants across 1 site.
Detailed Summary
This is a prospective, single-center study to assess the long- and short-term outcomes of ticagrelor vs clopidogrel in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention. Patients will undergo face-to-face interviews, phone calls, or/and chart reviews at 7 days, 1 month, 6 months and 12 months. When 4500 patients have completed the follow-up, an interim analysis will be performed.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Coronary Syndrome
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartAug 2014
First PostedAug 2017
Primary CompletionOct 2021
TodayJul 2026
First PostedAug 3, 2017
Enrollment StartAug 1, 2014
Primary CompletionOct 24, 2021
TodayJul 2, 2026
Enrollment to primary: 7.2 yearsPosted 8.9 years ago